Elizabeth J Geller1, Emma Babb2, Andrea G Nackley3, Denniz Zolnoun4. 1. Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: egeller@med.unc.edu. 2. School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 3. Center for Pain Research and Innovation, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Division of Advanced Laparoscopy and Pelvic Pain, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
STUDY OBJECTIVE: Our aim was to assess incidence and risk factors for pelvic pain after pelvic mesh implantation. DESIGN: Retrospective study (Canadian Task Force classification II-2). SETTING: Single university hospital. PATIENTS: Women who have undergone surgery with pelvic mesh implant for treatment of pelvic floor disorders including prolapse and incontinence. INTERVENTIONS: Telephone interviews to assess pain, sexual function, and general health. MEASUREMENTS AND MAIN RESULTS: Pain was measured by the McGill Short-Form Pain Questionnaire for somatic pain, Neuropathic Pain Symptom Inventory for neuropathic pain, Pennebaker Inventory of Limbic Languidness for somatization, and Female Sexual Function Index (FSFI) for sexual health and dyspareunia. General health was assessed with the 12-item Short-Form Health Survey. Among 160 enrolled women, mean time since surgery was 20.8 ± 10.5 months, mean age was 62.1 ± 11.2 years, 93.8% were white, 86.3% were postmenopausal, and 3.1% were tobacco users. Types of mesh included midurethral sling for stress incontinence (78.8%), abdominal/robotic sacrocolpopexy (35.7%), transvaginal for prolapse (6.3%), and perirectal for fecal incontinence (1.9%), with 23.8% concomitant mesh implants for both prolapse and incontinence. Our main outcome, self-reported pelvic pain at least 1 year after surgery, was 15.6%. Women reporting pain were younger, with fibromyalgia, worse physical health, higher somatization, and lower surgery satisfaction (all p < .05). Current pelvic pain correlated with early postoperative pelvic pain (p < .001), fibromyalgia (p = .002), worse physical health (p = .003), and somatization (p = .003). Sexual function was suboptimal (mean FSFI, 16.2 ± 12.1). Only 54.0% were sexually active, with 19.0% of those reporting dyspareunia. CONCLUSION: One in 6 women reported de novo pelvic pain after pelvic mesh implant surgery, with decreased sexual function. Risk factors included younger age, fibromyalgia, early postoperative pain, poorer physical health, and somatization. Understanding risk factors for pelvic pain after mesh implantation may improve patient selection.
STUDY OBJECTIVE: Our aim was to assess incidence and risk factors for pelvic pain after pelvic mesh implantation. DESIGN: Retrospective study (Canadian Task Force classification II-2). SETTING: Single university hospital. PATIENTS: Women who have undergone surgery with pelvic mesh implant for treatment of pelvic floor disorders including prolapse and incontinence. INTERVENTIONS: Telephone interviews to assess pain, sexual function, and general health. MEASUREMENTS AND MAIN RESULTS:Pain was measured by the McGill Short-Form Pain Questionnaire for somatic pain, Neuropathic Pain Symptom Inventory for neuropathic pain, Pennebaker Inventory of Limbic Languidness for somatization, and Female Sexual Function Index (FSFI) for sexual health and dyspareunia. General health was assessed with the 12-item Short-Form Health Survey. Among 160 enrolled women, mean time since surgery was 20.8 ± 10.5 months, mean age was 62.1 ± 11.2 years, 93.8% were white, 86.3% were postmenopausal, and 3.1% were tobacco users. Types of mesh included midurethral sling for stress incontinence (78.8%), abdominal/robotic sacrocolpopexy (35.7%), transvaginal for prolapse (6.3%), and perirectal for fecal incontinence (1.9%), with 23.8% concomitant mesh implants for both prolapse and incontinence. Our main outcome, self-reported pelvic pain at least 1 year after surgery, was 15.6%. Women reporting pain were younger, with fibromyalgia, worse physical health, higher somatization, and lower surgery satisfaction (all p < .05). Current pelvic pain correlated with early postoperative pelvic pain (p < .001), fibromyalgia (p = .002), worse physical health (p = .003), and somatization (p = .003). Sexual function was suboptimal (mean FSFI, 16.2 ± 12.1). Only 54.0% were sexually active, with 19.0% of those reporting dyspareunia. CONCLUSION: One in 6 women reported de novo pelvic pain after pelvic mesh implant surgery, with decreased sexual function. Risk factors included younger age, fibromyalgia, early postoperative pain, poorer physical health, and somatization. Understanding risk factors for pelvic pain after mesh implantation may improve patient selection.
Authors: Shawn A Menefee; Keisha Y Dyer; Emily S Lukacz; Amanda J Simsiman; Karl M Luber; John N Nguyen Journal: Obstet Gynecol Date: 2011-12 Impact factor: 7.661
Authors: Nazema Y Siddiqui; Cara L Grimes; Elizabeth R Casiano; Husam T Abed; Peter C Jeppson; Cedric K Olivera; Tatiana V Sanses; Adam C Steinberg; Mary M South; Ethan M Balk; Vivian W Sung Journal: Obstet Gynecol Date: 2015-01 Impact factor: 7.661
Authors: Jennifer M Wu; Amie Kawasaki; Andrew F Hundley; Alexis A Dieter; Evan R Myers; Vivian W Sung Journal: Am J Obstet Gynecol Date: 2011-04-02 Impact factor: 8.661
Authors: Cheryl B Iglesia; Andrew I Sokol; Eric R Sokol; Bela I Kudish; Robert E Gutman; Joanna L Peterson; Susan Shott Journal: Obstet Gynecol Date: 2010-08 Impact factor: 7.661
Authors: Vivian W Sung; Rebecca G Rogers; Joseph I Schaffer; Ethan M Balk; Katrin Uhlig; Joseph Lau; Husam Abed; Thomas L Wheeler; Michelle Y Morrill; Jeffrey L Clemons; David D Rahn; James C Lukban; Lior Lowenstein; Kimberly Kenton; Stephen B Young Journal: Obstet Gynecol Date: 2008-11 Impact factor: 7.661
Authors: Maurice Theunissen; Madelon L Peters; Jan Schepers; Jacques W M Maas; Fleur Tournois; Hans A van Suijlekom; Hans-Fritz Gramke; Marco A E Marcus Journal: Medicine (Baltimore) Date: 2016-06 Impact factor: 1.889
Authors: Marcella G Willis-Gray; Jessica C Young; Virginia Pate; Michele Jonsson Funk; Jennifer M Wu Journal: Am J Obstet Gynecol Date: 2020-07-09 Impact factor: 8.661
Authors: Emily B Rosenfeld; Ladin A Yurteri-Kaplan; Chris Maher; Tony Bazi; Kamil Svabik; Sara Houlihan; Cara L Grimes Journal: Int Urogynecol J Date: 2019-12-02 Impact factor: 2.894
Authors: Roxanna E Abhari; Matthew L Izett-Kay; Hayley L Morris; Rufus Cartwright; Sarah J B Snelling Journal: Nat Rev Urol Date: 2021-09-20 Impact factor: 14.432
Authors: Ajay B Antony; B Carsten Schultheis; Suneil M Jolly; Daniel Bates; Corey W Hunter; Robert M Levy Journal: Pain Med Date: 2019-06-01 Impact factor: 3.750
Authors: Elliot K Blau; Sarah A Adelstein; Katherine A Amin; Sharon J Durfy; Alvaro Lucioni; Kathleen C Kobashi; Una J Lee Journal: Investig Clin Urol Date: 2019-11-15